Angela Santoni

Q: What Schools Are Affiliated With Angela Santoni

Angela Santoni is affiliated with the following schools: University of Milan, University of L'Aquila, University of Salerno, University of Brescia, University of Florence, University of Turin, Sapienza University of Rome, University of Bologna

Angela Santoni's AcademicInfluence.com Rankings

Angela Santoni

Biology

#7999

World Rank

#11006

Historical Rank

Immunology

#442

World Rank

#459

Historical Rank

biology Degrees

Download Badge

Biology

Angela Santoni's Degrees

Bachelors Biology University of Milan
Masters Immunology University of Milan

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2025

Why Is Angela Santoni Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Angela Santoni's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) (2019) (627)
Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase (1994) (594)
Natural Killer Cells: Characteristics and Regulation of Activity (1979) (578)
The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. (1994) (485)
The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. (1998) (455)
ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype. (2009) (397)
Neutrophil diversity and plasticity in tumour progression and therapy (2020) (349)
Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury. (2004) (307)
Tumor necrosis factor alters synaptic transmission in rat hippocampal slices (1992) (305)
Multiple pathways originate at the Fas/APO‐1 (CD95) receptor: sequential involvement of phosphatidylcholine‐specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. (1995) (295)
Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis. (2007) (288)
Vitamin D3: a transcriptional modulator of the interferon‐γ gene (1998) (258)
Interplay between Human Cytomegalovirus and Intrinsic/Innate Host Responses: A Complex Bidirectional Relationship (2012) (251)
Lymphokine-activated killer cell activity Characteristics of effector cells and their progenitors in blood and spleen. (1987) (250)
Cross-Talk between Activated Human NK Cells and CD4+ T Cells via OX40-OX40 Ligand Interactions1 (2004) (214)
Recruitment of circulating NK cells through decidual tissues: a possible mechanism controlling NK cell accumulation in the uterus during early pregnancy. (2008) (214)
Dexamethasone-induced thymocyte apoptosis: apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase, and caspases. (1999) (194)
Analysis of the role of chemokines in angiogenesis. (2003) (191)
Involvement of p21ras activation in T cell CD69 expression (1994) (190)
Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors (1994) (186)
Steroid sensitivity of thymocyte subpopulations during intrathymic differentiation. Effects of 17 beta-estradiol and dexamethasone on subsets expressing T cell antigen receptor or IL-2 receptor. (1989) (183)
Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity. (2007) (183)
In vivo natural reactivity of mice against tumor cells (1980) (183)
The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. (1998) (181)
Rapid in vivo assay of mouse natural killer cell activity. (1979) (173)
IL-1R8 is a checkpoint in NK cells regulating anti-tumor and anti-viral activity (2017) (162)
CD8 Cell Division Maintaining Cytotoxic Memory Occurs Predominantly in the Bone Marrow1 (2005) (147)
Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect. (2004) (145)
Vitamin D3: a transcriptional modulator of the interferon-gamma gene. (1998) (142)
NKG2D and Its Ligands: “One for All, All for One” (2018) (142)
CXC chemokines interleukin-8 (IL-8) and growth-related gene product α (GROα) modulate Purkinje neuron activity in mouse cerebellum (1998) (134)
Specific engagement of the CD94/NKG2‐A killer inhibitory receptor by the HLA‐E class Ib molecule induces SHP‐1 phosphatase recruitment to tyrosine‐phosphorylated NKG2‐A: evidence for receptor function in heterologous transfectants (1998) (129)
Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes. A potential role for the acidic sphingomyelinase pathway in normal immunoregulation. (1996) (129)
An Alternative Role of C1q in Cell Migration and Tissue Remodeling: Contribution to Trophoblast Invasion and Placental Development (2010) (126)
Interleukin-2 suppresses established long-term potentiation and inhibits its induction in the rat hippocampus (1990) (125)
Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial. (2017) (125)
DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction. (2011) (124)
Identification of the CC chemokines TARC and macrophage inflammatory protein‐1β as novel functional ligands for the CCR8 receptor (1998) (123)
p38 MAPK activation controls the TLR3-mediated up-regulation of cytotoxicity and cytokine production in human NK cells. (2004) (122)
Lymphokine-activated tumor inhibition in vivo. I. The local administration of interleukin 2 triggers nonreactive lymphocytes from tumor-bearing mice to inhibit tumor growth. (1985) (120)
The Human Immunodeficiency Virus Type 1 Nef and Vpu Proteins Downregulate the Natural Killer Cell-Activating Ligand PVR (2012) (119)
RAC1/P38 MAPK signaling pathway controls beta1 integrin-induced interleukin-8 production in human natural killer cells. (2000) (118)
SDF‐1α‐mediated modulation of synaptic transmission in rat cerebellum (2000) (117)
CCL3 and CXCL12 regulate trafficking of mouse bone marrow NK cell subsets. (2008) (110)
bcl‐2 over‐expression enhances NF‐κB activity and induces mmp‐9 transcription in human MCF7ADR breast‐cancer cells (2000) (109)
Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors (2012) (107)
The DNA Damage Response: A Common Pathway in the Regulation of NKG2D and DNAM-1 Ligand Expression in Normal, Infected, and Cancer Cells (2014) (105)
Role of Distinct Natural Killer Cell Subsets in Anticancer Response (2017) (105)
Regulation of PD-L1 Expression by NF-κB in Cancer (2020) (102)
Enriched environment reduces glioma growth through immune and non-immune mechanisms in mice (2015) (101)
CD69 is expressed on platelets and mediates platelet activation and aggregation (1990) (101)
NK cells and interferons. (2015) (100)
Transfer to cyclophosphamide-treated mice of natural killer (NK) cells and in vivo natural reactivity against tumors. (1981) (99)
Opioid-Induced Tolerance and Hyperalgesia (2019) (99)
Oxidative stress inhibits IFN-alpha-induced antiviral gene expression by blocking the JAK-STAT pathway. (2006) (96)
Human natural killer cells express VLA-4 and VLA-5, which mediate their adhesion to fibronectin. (1991) (95)
The Cytoskeleton Regulatory Protein hMena (ENAH) Is Overexpressed in Human Benign Breast Lesions with High Risk of Transformation and Human Epidermal Growth Factor Receptor-2–Positive/Hormonal Receptor–Negative Tumors (2006) (95)
Reactivity of Anti‐Asialo GM1 Serum With Tumoricidal and Non‐Tumoricidal Mouse Macrophages (1985) (95)
Human mena protein, a serex‐defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T‐cell immune response (2004) (95)
NK cell regulation of T cell-mediated responses. (2005) (95)
I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo. (2000) (91)
Role for the Rac1 exchange factor Vav in the signaling pathways leading to NK cell cytotoxicity. (1999) (90)
Molecular cloning of hMena (ENAH) and its splice variant hMena+11a: epidermal growth factor increases their expression and stimulates hMena+11a phosphorylation in breast cancer cell lines. (2007) (88)
Toward highly potent cancer agents by modulating the C-2 group of the arylthioindole class of tubulin polymerization inhibitors. (2013) (88)
Cytokine Production (IL-1α, IL-1β, and TNFα) and Endothelial Cell Activation (ELAM-1 and HLA-DR) in Reactive Lymphadenitis, Hodgkin's Disease, and in Non-Hodgkin's Lymphomas: An Immunocytochemical Study (1990) (88)
Inhibition of tumor growth and enhancement of metastasis after transfection of the γ‐interferon gene (1993) (87)
Activation of Syk Tyrosine Kinase Is Required for c-Cbl-mediated Ubiquitination of FcεRI and Syk in RBL Cells* (2002) (86)
Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine production: Role of HSP70/TLR2/NF-kB axis (2017) (86)
Interleukin 2 activated tumor inhibition in vivo depends on the systemic involvement of host immunoreactivity. (1987) (85)
Pathophysiology of ageing, longevity and age related diseases (2007) (85)
Continuous in vivo activation and transient hyporesponsiveness to TcR/CD3 triggering of human gut lamina propria lymphocytes (1993) (84)
Integrin-mediated Ras–Extracellular Regulated Kinase (ERK) Signaling Regulates Interferon γ Production in Human Natural Killer Cells (1998) (83)
Negative Regulation of CD95 Ligand Gene Expression by Vitamin D3 in T Lymphocytes1 (2002) (82)
Natural Killer Cell Response to Chemotherapy-Stressed Cancer Cells: Role in Tumor Immunosurveillance (2017) (82)
CD44 triggering enhances human NK cell cytotoxic functions. (1994) (79)
Radiofrequency destruction of the tuberoinfundibular region of hypothalamus permanently abrogates NK cell activity in mice (1983) (79)
Dysregulation of Chemokine/Chemokine Receptor Axes and NK Cell Tissue Localization during Diseases (2016) (78)
Genotoxic Stress Induces Senescence-Associated ADAM10-Dependent Release of NKG2D MIC Ligands in Multiple Myeloma Cells (2015) (78)
Kinetics of In Vivo Proliferation and Death of Memory and Naive CD8 T Cells: Parameter Estimation Based on 5-Bromo-2′-Deoxyuridine Incorporation in Spleen, Lymph Nodes, and Bone Marrow 1 (2008) (77)
Soluble interleukin‐2 receptor, interleukin‐2 and interleukin‐4 in sera and supernatants from patients with progressive systemic sclerosis (1990) (77)
Proline-rich tyrosine kinase-2 activation by beta 1 integrin fibronectin receptor cross-linking and association with paxillin in human natural killer cells. (1997) (76)
The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma (2015) (76)
CD16 cross-linking induces both secretory and extracellular signal-regulated kinase (ERK)-dependent cytosolic phospholipase A2 (PLA2) activity in human natural killer cells: involvement of ERK, but not PLA2, in CD16-triggered granule exocytosis. (1997) (76)
Effects of adriamycin on the activity of mouse natural killer cells. (1980) (75)
SH2-containing inositol phosphatase (SHIP-1) transiently translocates to raft domains and modulates CD16-mediated cytotoxicity in human NK cells. (2002) (75)
Reactive Oxygen Species– and DNA Damage Response–Dependent NK Cell Activating Ligand Upregulation Occurs at Transcriptional Levels and Requires the Transcriptional Factor E2F1 (2014) (75)
Modulation of the neurotransmitter release in rat cerebellar neurons by GROβ (1998) (75)
Bone marrow CD8 T cells are in a different activation state than those in lymphoid periphery (2002) (75)
Chemokines and glioma: Invasion and more (2010) (74)
Interleukin-2-activated rat natural killer cells express inducible nitric oxide synthase that contributes to cytotoxic function and interferon-gamma production. (1999) (74)
Soluble ligands for the NKG2D receptor are released during HIV‐1 infection and impair NKG2D expression and cytotoxicity of NK cells (2013) (74)
Transcriptional regulation of the interleukin 2 gene by glucocorticoid hormones. Role of steroid receptor and antigen-responsive 5'-flanking sequences. (1990) (74)
Chemerin regulates NK cell accumulation and endothelial cell morphogenesis in the decidua during early pregnancy. (2012) (73)
Molecular cloning of TER1, a chemokine receptor-like gene expressed by lymphoid tissues. (1996) (73)
Multiple Myeloma Impairs Bone Marrow Localization of Effector Natural Killer Cells by Altering the Chemokine Microenvironment. (2015) (71)
Memory T-cell competition for bone marrow seeding (2003) (71)
Obligatory role of IFN-gamma in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicity. (1988) (71)
CD69‐triggered ERK activation and functions are negatively regulated by CD94 / NKG2‐A inhibitory receptor (2000) (69)
Proline-Rich Tyrosine Kinase 2 and Rac Activation by Chemokine and Integrin Receptors Controls NK Cell Transendothelial Migration1 (2003) (69)
Cutting Edge: Functional Role for Proline-Rich Tyrosine Kinase 2 in NK Cell-Mediated Natural Cytotoxicity1 (2000) (67)
The Senescence-Associated Secretory Phenotype (SASP) in the Challenging Future of Cancer Therapy and Age-Related Diseases (2020) (67)
CXC chemokines interleukin-8 (IL-8) and growth-related gene product alpha (GROalpha) modulate Purkinje neuron activity in mouse cerebellum. (1998) (67)
Detuning CD8+ T lymphocytes by down-regulation of the activating receptor NKG2D: role of NKG2D ligands released by activated T cells. (2009) (66)
Multifunctional human CD56low CD16low natural killer cells are the prominent subset in bone marrow of both healthy pediatric donors and leukemic patients (2015) (66)
The chemokine growth-related gene product β protects rat cerebellar granule cells from apoptotic cell death through α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors (2000) (65)
Ubiquitination and degradation of Syk and ZAP-70 protein tyrosine kinases in human NK cells upon CD16 engagement (2001) (65)
CX3CR1/CX3CL1 axis negatively controls glioma cell invasion and is modulated by transforming growth factor-β1. (2010) (64)
Estrogen and antiestrogen modulation of the levels of mouse natural killer activity and large granular lymphocytes. (1987) (64)
Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of cMYC-IRF4-miR-125b interplay (2016) (63)
Design and synthesis of 2-heterocyclyl-3-arylthio-1H-indoles as potent tubulin polymerization and cell growth inhibitors with improved metabolic stability. (2011) (63)
Role of the α5β1 Integrin Receptor in the Proliferative Response of Quiescent Human Melanoma Cells to Fibronectin (1992) (62)
Heat Shock Protein-90 Inhibitors Increase MHC Class I-Related Chain A and B Ligand Expression on Multiple Myeloma Cells and Their Ability to Trigger NK Cell Degranulation1 (2009) (62)
Reduced natural killer cell activity in major depression: neuroendocrine implications (1989) (62)
CIN85 Regulates the Ligand-Dependent Endocytosis of the IgE Receptor: A New Molecular Mechanism to Dampen Mast Cell Function1 (2005) (61)
Natural Killer (NK) Cells from Killers to Regulators: Distinct Features Between Peripheral Blood and Decidual NK Cells (2007) (60)
Impaired NK-cell migration in WAS/XLT patients: role of Cdc42/WASp pathway in the control of chemokine-induced beta2 integrin high-affinity state. (2010) (60)
Inhibition of Glycogen Synthase Kinase-3 Increases NKG2D Ligand MICA Expression and Sensitivity to NK Cell–Mediated Cytotoxicity in Multiple Myeloma Cells: Role of STAT3 (2013) (60)
Cytotoxic effector cells with the characteristics of natural killer cells in the lungs of mice (1980) (60)
Role of nitric oxide in cell-mediated tumor cytotoxicity. (1995) (59)
Uterine NK cell development, migration and function. (2008) (59)
Retinoic Acid-induced Transcriptional Modulation of the Human Interferon-γ Promoter* (1996) (58)
Natural killer (NK) cells and anti‐tumor therapeutic mAb: unexplored interactions (2016) (58)
Suppression of activity of mouse natural killer (NK) cells by activated macrophages from mice treated with pyran copolymer (1980) (58)
REVIEW ARTICLE: Mechanisms Underlying Recruitment and Accumulation of Decidual NK Cells in Uterus During Pregnancy (2008) (57)
NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: role in the NK cell-mediated negative regulation of T cell responses (2013) (57)
In vivo reactivity of mouse natural killer (NK) cells against normal bone marrow cells. (1981) (56)
Natural killer cells and nitric oxide. (2001) (56)
Natural killer cells modulate motor neuron-immune cell cross talk in models of Amyotrophic Lateral Sclerosis (2020) (56)
Candida albicans expresses a fibronectin receptor antigenically related to α5β1 integrin (1994) (56)
Interferon inhibits synaptic potentiation in rat hippocampus (1991) (56)
NKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple Myeloma (2015) (55)
Induction of the nitric oxide-synthesizing pathway in fresh and interleukin 2-cultured rat natural killer cells. (1994) (55)
CD16-mediated p21ras activation is associated with Shc and p36 tyrosine phosphorylation and their binding with Grb2 in human natural killer cells (1996) (55)
Polyclonal B lymphocyte activation in progressive systemic sclerosis. (1989) (53)
TNF-α increases the frequency of spontaneous miniature synaptic currents in cultured rat hippocampal neurons (1994) (53)
Differential chemotactic receptor requirements for NK cell subset trafficking into bone marrow (2013) (53)
Src-Dependent Syk Activation Controls CD69-Mediated Signaling and Function on Human NK Cells1 (2002) (53)
Key role of proline‐rich tyrosine kinase 2 in interleukin‐8 (CXCL8/IL‐8)‐mediated human neutrophil chemotaxis (2004) (52)
Chemokines and NK cells: Regulators of development, trafficking and functions (2012) (52)
Dichotomic effects of IFN‐γ on the development of systemic lupus erythematosus‐like syndrome in MRL‐lpr / lpr mice (2000) (52)
CXCR3/CXCL10 Axis Regulates Neutrophil–NK Cell Cross-Talk Determining the Severity of Experimental Osteoarthritis (2017) (52)
Regulation of NKG2D-Dependent NK Cell Functions: The Yin and the Yang of Receptor Endocytosis (2017) (51)
Interaction between dendritic cells and natural killer cells during pregnancy in mice (2008) (51)
CD94/NKG2-A inhibitory complex blocks CD16-triggered Syk and extracellular regulated kinase activation, leading to cytotoxic function of human NK cells. (1999) (51)
Regulation of Natural Killer Cell Activity (1984) (50)
Correlation between natural and antibody-dependent cell-mediated cytotoxicity against tumor targets in the mouse. I. Distribution of the reactivity. (1979) (50)
CX3CR1 expression defines 2 KLRG1+ mouse NK-cell subsets with distinct functional properties and positioning in the bone marrow. (2011) (50)
The chemokine receptor CCR8 mediates rescue from dexamethasone‐induced apoptosis via an ERK‐dependent pathway (2003) (49)
Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cells (2014) (49)
SDF-1alpha-mediated modulation of synaptic transmission in rat cerebellum. (2000) (48)
Correction: Disease-specific protein corona sensor arrays may have disease detection capacity (2019) (48)
Gut microbiota alterations affect glioma growth and innate immune cells involved in tumor immunosurveillance in mice (2019) (48)
Interleukin 1-β-induced protein kinase C-ζ activation is mimicked by exogenous phospholipase D (1997) (47)
The Use of Filamentous Bacteriophage fd to Deliver MAGE-A10 or MAGE-A3 HLA-A2-Restricted Peptides and to Induce Strong Antitumor CTL Responses1 (2008) (47)
Transcriptional regulation of interleukin‐2 gene expression by CD69‐generated signals (1993) (47)
Ubiquitin-dependent endocytosis of NKG2D-DAP10 receptor complexes activates signaling and functions in human NK cells (2015) (46)
Drug-Induced Senescent Multiple Myeloma Cells Elicit NK Cell Proliferation by Direct or Exosome-Mediated IL15 Trans-Presentation (2018) (45)
Arf6 : a new player in fcγriiia lymphocyte-mediated cytotoxicity (2005) (45)
Senescent cells: Living or dying is a matter of NK cells (2019) (45)
Effects of cadmium on lymphocyte activation. (1989) (45)
Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation (2015) (44)
Changes in number and density of large granular lymphocytes upon in vivo augmentation of mouse natural killer activity. (1985) (44)
Granzyme B is expressed in urothelial carcinoma and promotes cancer cell invasion (2009) (44)
High-efficient lentiviral vector-mediated gene transfer into primary human NK cells. (2006) (43)
Correlation between natural and antibody-dependent cell-mediated cytotoxicity against tumor targets in the mouse. II. Characterization of the effector cells. (1979) (43)
Suppression of natural killer (NK) activity by splenic adherent cells of low NK‐reactive mice (1981) (43)
Overexpression of transient receptor potential mucolipin-2 ion channels in gliomas: role in tumor growth and progression (2016) (43)
Functional role of α4β1 and α5β1 integrin fibronectin receptors expressed on adriamycin‐resistant MCF‐7 human mammary carcinoma cells (1997) (43)
Axitinib induces DNA damage response leading to senescence, mitotic catastrophe, and increased NK cell recognition in human renal carcinoma cells (2015) (42)
Regulation of Fc Receptor Endocytic Trafficking by Ubiquitination (2014) (41)
Immunoreactivity for IL-1 beta and TNF alpha in human lymphoid and nonlymphoid tissues. (1989) (41)
Arf6: a new player in FcgammaRIIIA lymphocyte-mediated cytotoxicity. (2005) (41)
“Immuno-Transient Receptor Potential Ion Channels”: The Role in Monocyte- and Macrophage-Mediated Inflammatory Responses (2018) (41)
Mitogenic activity of laminin on human melanoma and melanocytes: different signal requirements and role of beta 1 integrins. (1995) (40)
The adaptor protein shc is involved in the negative regulation of NK cell‐mediated cytotoxicity (2001) (40)
Differential expression of granzyme A and granzyme B proteases and their secretion by fresh rat natural killer cells (NK) and lymphokine‐activated killer cells with NK phenotype (LAK‐NK) (1992) (40)
Hyperthermia Enhances CD95-Ligand Gene Expression in T Lymphocytes1 (2005) (39)
Immunoregulatory and Effector Activities of Nitric Oxide and Reactive Nitrogen Species in Cancer. (2016) (39)
Cross-linking of alpha 4 beta 1 and alpha 5 beta 1 fibronectin receptors enhances natural killer cell cytotoxic activity. (1995) (39)
Signaling pathways activated by chemokine receptor CXCR2 and AMPA-type glutamate receptors and involvement in granule cells survival (2002) (39)
CD155: A Multi-Functional Molecule in Tumor Progression (2020) (39)
Anti-CD20 Therapy Acts via FcγRIIIA to Diminish Responsiveness of Human Natural Killer Cells. (2015) (39)
Docosahexaenoic acid (DHA) promotes immunogenic apoptosis in human multiple myeloma cells, induces autophagy and inhibits STAT3 in both tumor and dendritic cells (2017) (38)
CX3CR1 Regulates the Maintenance of KLRG1+ NK Cells into the Bone Marrow by Promoting Their Entry into Circulation (2013) (38)
JAK/STAT signaling in regulation of innate lymphoid cells: The gods before the guardians (2018) (38)
Characterization by somatic cell genetics of a monoclonal antibody to the MDR1 gene product (P‐glycoprotein): Determination of p‐glycoprotein expression in multi‐drug‐resistant kb and cem cell variants (1991) (38)
In vivo cadmium treatment alters natural killer activity and large granular lymphocyte number in the rat. (1989) (38)
Regulation of NKG2D Expression and Signaling by Endocytosis. (2016) (37)
The Cyclopentenone-Type Prostaglandin 15-Deoxy-Δ12,14-Prostaglandin J2 Inhibits CD95 Ligand Gene Expression in T Lymphocytes: Interference with Promoter Activation Via Peroxisome Proliferator-Activated Receptor-γ-Independent Mechanisms1 (2003) (37)
New Indole Tubulin Assembly Inhibitors Cause Stable Arrest of Mitotic Progression, Enhanced Stimulation of Natural Killer Cell Cytotoxic Activity, and Repression of Hedgehog-Dependent Cancer. (2015) (37)
Bone marrow CD8 cells down-modulate membrane IL-7Ralpha expression and exhibit increased STAT-5 and p38 MAPK phosphorylation in the organ environment. (2007) (36)
Environmental stimuli shape microglial plasticity in glioma (2017) (36)
Beta 1 integrin cross-linking inhibits CD16-induced phospholipase D and secretory phospholipase A2 activity and granule exocytosis in human NK cells: role of phospholipase D in CD16-triggered degranulation. (1999) (36)
Long term activation of natural killer cells results in modulation of beta 1-integrin expression and function. (1994) (35)
Follicle-stimulating hormone-induced phospholipase A2 activity and eicosanoid generation in rat Sertoli cells. (1994) (35)
Expansion of cytotoxic effectors with lytic activity against autologous blasts from acute myeloid leukaemia patients in complete haematological remission (2002) (35)
Capsaicin-mediated apoptosis of human bladder cancer cells activates dendritic cells via CD91. (2015) (35)
Recognition of a carbohydrate xenoepitope by human NKRP1A (CD161) (2006) (34)
Hepatitis C virus direct‐acting antivirals therapy impacts on extracellular vesicles microRNAs content and on their immunomodulating properties (2018) (34)
The multifaceted role of PIP2 in leukocyte biology (2015) (34)
Triggering through CD16 or phorbol esters enhances adhesion of NK cells to laminin via very late antigen 6 (1992) (34)
Tyrosine kinase‐dependent activation of human NK cell functions upon triggering through CD44 receptor (1996) (34)
Tumor immunotherapy by local injection of interleukin 2 and non-reactive lymphocytes. Experimental and clinical results. (1988) (34)
Re: Gut Microbiome Influences Efficacy of PD-1-based Immunotherapy Against Epithelial Tumors. (2018) (33)
Chemotherapy-elicited upregulation of NKG2D and DNAM-1 ligands as a therapeutic target in multiple myeloma (2013) (33)
Activation of mouse macrophages by pyran copolymer and role in augmentation of natural killer activity (1979) (33)
c‐Cbl regulates MICA‐ but not ULBP2‐induced NKG2D down‐modulation in human NK cells (2014) (33)
Lipid Raft-Dependent FcεRI Ubiquitination Regulates Receptor Endocytosis through the Action of Ubiquitin Binding Adaptors (2009) (33)
Activation of Syk tyrosine kinase is required for c-Cbl-mediated ubiquitination of Fcepsilon RI and Syk in RBL cells. (2002) (33)
Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock. (1995) (33)
Epitelial-to-mesenchimal transition and invasion are upmodulated by tumor-expressed granzyme B and inhibited by docosahexaenoic acid in human colorectal cancer cells (2016) (33)
The yin‐yang of the interaction between myelomonocytic cells and NK cells (2018) (33)
Natural killer cell recognition of in vivo drug-induced senescent multiple myeloma cells (2016) (33)
Activin A as a Mediator of NK–Dendritic Cell Functional Interactions (2014) (32)
PIP2-dependent regulation of Munc13-4 endocytic recycling: impact on the cytolytic secretory pathway. (2012) (32)
CD16‐mediated activation of phosphatidylinositol‐3 kinase (Pl‐3K) in human NK cells involves tyrosine phosphorylation of Cbl and its association with Grb2, Shc, pp36 and p85 Pl‐3K subunit (1998) (32)
Production of MCP-1 and RANTES in bladder cancer patients after bacillus Calmette-Guerin immunotherapy (2002) (32)
Cancer Exosomes as Conveyors of Stress-Induced Molecules: New Players in the Modulation of NK Cell Response (2019) (32)
Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and Cancer (2020) (31)
Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ production (2017) (31)
Selective binding of shc-SH2 domain to tyrosine-phosphorylated zeta but not gamma-chain upon CD16 ligation on human NK cells. (1997) (31)
Ubiquitination and endocytosis of the high affinity receptor for IgE. (2010) (30)
Preferential involvement of a phospholipase A2-dependent pathway in CD69-mediated platelet activation. (1992) (30)
Hypothalamic control of certain aspects of natural immunity in the mouse. (1987) (29)
Tumour inhibition by interleukin-2 at the tumour/host interface. (1986) (29)
Cancer-Associated CD43 Glycoforms as Target of Immunotherapy (2013) (29)
PI5KI-dependent signals are critical regulators of the cytolytic secretory pathway. (2008) (29)
NKG2A inhibits NKG2C effector functions of γδ T cells: implications in health and disease (2011) (29)
In Vivo Imaging of Natural Killer Cell Trafficking in Tumors (2015) (29)
Adriamycin-induced antitumor response in lethally irradiated mice. (1979) (28)
Axitinib induces senescence-associated cell death and necrosis in glioma cell lines: The proteasome inhibitor, bortezomib, potentiates axitinib-induced cytotoxicity in a p21(Waf/Cip1) dependent manner (2016) (28)
μ3 Opiate receptor expression in lung and lung carcinoma : ligand binding and coupling to nitric oxide release (1999) (28)
Tumor-associated and immunochemotherapy-dependent long-term alterations of the peripheral blood NK cell compartment in DLBCL patients (2015) (28)
NCR+ ILC3 maintain larger STAT4 reservoir via T‐BET to regulate type 1 features upon IL‐23 stimulation in mice (2018) (28)
Augmentation of natural killer activity by pyran copolymer in mice (1979) (28)
Involvement of phospholipase A2 activation and arachidonic acid metabolism in the cytotoxic functions of rat NK cells. (1993) (28)
The Growth-related Gene Product β Induces Sphingomyelin Hydrolysis and Activation of c-Jun N-terminal Kinase in Rat Cerebellar Granule Neurones* (1999) (28)
Distinct Roles for Human Cytomegalovirus Immediate Early Proteins IE1 and IE2 in the Transcriptional Regulation of MICA and PVR/CD155 Expression (2016) (27)
Effects of protein kinase C (PK-C) activators and inhibitors on human large granular lymphocytes (LGL): role of PK-C on natural killer (NK) activity. (1989) (27)
Immunological and non‐immunological influence of H‐2Kb gene transfection on the metastatic ability of B16 melanoma cells (1991) (27)
NKG2D/Ligand dysregulation and functional alteration of innate immunity cell populations in pediatric IBD (2012) (27)
Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis. (2008) (27)
Murine monoclonal antibody recognizing a 90‐kDa cell‐surface determinant selectively lost by multi‐drug‐resistant variants of cem cells (1990) (26)
NKR-P1A stimulation of arachidonate-generating enzymes in rat NK cells is associated with granule release and cytotoxic activity. (1997) (26)
The Adaptor Molecule CIN85 Regulates Syk Tyrosine Kinase Level by Activating the Ubiquitin-Proteasome Degradation Pathway1 (2007) (26)
Alloantigen-activated lymphocytes from mice bearing a spontaneous "nonimmunogenic" adenocarcinoma inhibit its growth in vivo by recruiting host immunoreactivity. (1985) (26)
Identification of a Genetic Variation in ERAP1 Aminopeptidase that Prevents Human Cytomegalovirus miR-UL112-5p-Mediated Immunoevasion. (2017) (26)
IL‐15 inhibits IL‐7Rα expression by memory‐phenotype CD8+ T cells in the bone marrow (2012) (26)
Rat natural killer cells synthesize fibronectin. Possible involvement in the cytotoxic function. (1989) (25)
MICA-129 Dimorphism and Soluble MICA Are Associated With the Progression of Multiple Myeloma (2018) (25)
Local immunotherapy of superficial bladder cancer by intravesical instillation of recombinant interleukin-2. (1995) (25)
Evaluation of degranulation and cytokine production in natural killer cells from spondyloarthritis patients at single‐cell level (2011) (24)
NKG2D Ligand Shedding in Response to Stress: Role of ADAM10 (2020) (24)
Isolation and chromosomal localization of GPR31, a human gene encoding a putative G protein-coupled receptor. (1997) (24)
Innate immune activating ligand SUMOylation affects tumor cell recognition by NK cells (2017) (24)
The Cooperation between hMena Overexpression and HER2 Signalling in Breast Cancer (2010) (24)
The lymphoepithelial organization of the tonsil: An immunohistochemical study in chronic recurrent tonsillitis (1995) (24)
Cloning of a novel human RNA polymerase II subunit downregulated by doxorubicin: new potential mechanisms of drug related toxicity (1996) (23)
Reduction of spontaneous autoimmune diabetes in diabetes-prone BB rats with the novel immunosuppressant fusidic acid. Effect on T-cell proliferation and production of interferon-gamma. (1994) (23)
INHIBITION AS WELL AS AUGMENTATION OF MOUSE NK ACTIVITY BY PYRAN COPOLYMER AND ADRIAMYCIN (1980) (23)
Stimulation of protein tyrosine phosphorylation by interaction of NK cells with fibronectin via alpha 4 beta 1 and alpha 5 beta 1. (1995) (23)
Targeting NKG2D and NKp30 Ligands Shedding to Improve NK Cell-Based Immunotherapy. (2016) (23)
The chemokine growth-related gene product beta protects rat cerebellar granule cells from apoptotic cell death through alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors. (2000) (23)
Vaccines: An achievement of civilization, a human right, our health insurance for the future (2018) (23)
Chemoattractant induces LFA‐1 associated PI 3K activity and cell migration that are dependent on Fyn signaling (2005) (23)
Chemokine regulation of innate lymphoid cell tissue distribution and function. (2018) (22)
Continuous intra‐arterial administration of recombinant interleukin‐2 in low‐stage bladder cancer. A phase IB study (1991) (22)
Key Role of the CD56lowCD16low Natural Killer Cell Subset in the Recognition and Killing of Multiple Myeloma Cells (2018) (22)
Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study. (1990) (22)
Targeting of CXCR3 improves anti-myeloma efficacy of adoptively transferred activated natural killer cells (2019) (22)
Candida albicans expresses a fibronectin receptor antigenically related to alpha 5 beta 1 integrin. (1994) (22)
Counter-regulation of regulatory T cells by autoreactive CD8+ T cells in rheumatoid arthritis. (2019) (21)
Translating the anti-myeloma activity of Natural Killer cells into clinical application. (2018) (21)
Regulation and trafficking of the HLA‐E molecules during monocyte‐macrophage differentiation (2016) (21)
ROLE OF NK CELLS IN RAPID IN VIVO CLEARANCE OF RADIOLABELED TUMOR CELLS (1980) (21)
Effect of prolonged administration of low doses of dietary retinoids on cell-mediated immunity and the growth of transplantable tumors in mice. (1986) (21)
p38 MAPK differentially controls NK activating ligands at transcriptional and post-transcriptional level on multiple myeloma cells (2017) (21)
p 38 MAPK activation controls the TLR 3-mediated up-regulation of cytotoxicity and cytokine production in human NK cells (2004) (20)
Retinoic acid-induced transcriptional modulation of the human interferon-gamma promoter. (1996) (20)
Diacylglycerol lipase activation and 5‐lipoxygenase activation and translocation following TCR/CD3 triggering in T cells (1995) (20)
When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancer (2020) (20)
Cadmium inhibits spontaneous (NK), antibody-mediated (ADCC) and IL-2-stimulated cytotoxic functions of natural killer cells. (1990) (20)
Granzyme A and CD160 expression delineates ILC1 with graded functions in the mouse liver (2021) (20)
The Ubiquitin‐proteasome pathway regulates Nectin2/CD112 expression and impairs NK cell recognition and killing (2018) (19)
Size and dynamics of mucosal and peripheral IL-17A+ T-cell pools in pediatric age, and their disturbance in celiac disease (2012) (19)
Mitogenic activity of fibronectin and laminin on human melanoma is mediated by β1 integrins: 251 (1993) (19)
Effector Functions of Natural Killer Cell Subsets in the Control of Hematological Malignancies (2015) (19)
Natural killer activity and antibody‐dependent cellular cytotoxicity in progressive systemic sclerosis (1990) (19)
Tyrosine kinase‐dependent ubiquitination of CD16 ζ subunit in human NK cells following receptor engagement (1999) (19)
Tumor-Targeting Anti-CD20 Antibodies Mediate In Vitro Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and In Vivo Priming (2018) (19)
Functional analysis of α1β1 integrin in human natural killer cells (1996) (19)
Reconstitution of multifunctional CD56lowCD16low natural killer cell subset in children with acute leukemia given α/β T cell-depleted HLA-haploidentical haematopoietic stem cell transplantation (2017) (19)
Functional role of alpha4beta1 and alpha5beta1 integrin fibronectin receptors expressed on adriamycin-resistant MCF-7 human mammary carcinoma cells. (1997) (19)
Attenuation of PI3K/Akt-Mediated Tumorigenic Signals through PTEN Activation by DNA Vaccine-Induced Anti-ErbB2 Antibodies (2010) (19)
H‐2Kb AND H‐2Db gene transfections in B16 melanoma differently affect non‐immunological properties relevant to the metastatic process. Involvement of integrin molecules (1994) (19)
Expression of interleukin 15 (IL‐15) in human rhabdomyosarcoma, osteosarcoma and Ewing's sarcoma (1997) (18)
TNF-alpha increases the frequency of spontaneous miniature synaptic currents in cultured rat hippocampal neurons. (1994) (18)
Activation of Lymphocyte Cytolytic Machinery: Where are We? (2013) (18)
Hitting More Birds with a Stone: Impact of TGF-β on ILC Activity in Cancer (2020) (18)
Tissue distribution of very late activation antigens-1/6 and very late activation antigen ligands in the normal thymus and in thymoma. (1993) (18)
Bone Marrow NK Cells: Origin, Distinctive Features, and Requirements for Tissue Localization (2019) (18)
Antigen‐specific CD8 T cells in cell cycle circulate in the blood after vaccination (2019) (18)
Negative signals from FcεRI engagement attenuate mast cell functions (2007) (18)
Syk‐dependent regulation of Hrs phosphorylation and ubiquitination upon FcεRI engagement: Impact on Hrs membrane/cytosol localization (2012) (17)
Ex vivo acidic preconditioning enhances bone marrow ckit+ cell therapeutic potential via increased CXCR4 expression (2011) (17)
Polyfunctional Melan-A-specific tumor-reactive CD8+ T cells elicited by dacarbazine treatment before peptide-vaccination depends on AKT activation sustained by ICOS (2016) (17)
Defective expression of the T‐cell receptor‐CD3 ζ chain in T‐cell acute lymphoblastic leukaemia (2003) (17)
Enhancement of natural‐killer‐cell susceptibility of human breast‐cancer cells by estradiol and v‐Ha‐ras Oncogene (1991) (17)
How Mucosal Epithelia Deal with Stress: Role of NKG2D/NKG2D Ligands during Inflammation (2017) (17)
Multiple Levels of Chemokine Receptor Regulation in the Control of Mouse Natural Killer Cell Development (2014) (16)
Post-transcriptional regulation of 5'-untranslated regions of human Transient Receptor Potential Vanilloid type-1 (TRPV-1) channels: role in the survival of glioma patients (2016) (16)
15-Deoxy-Δ12,14-Prostaglandin J2 Negatively Regulates rankl Gene Expression in Activated T Lymphocytes: Role of NF-κB and Early Growth Response Transcription Factors1 (2007) (16)
Ras inhibition amplifies cisplatin sensitivity of human glioblastoma. (2004) (16)
Bone Marrow Stromal Cell-Derived IL-8 Upregulates PVR Expression on Multiple Myeloma Cells via NF-kB Transcription Factor (2020) (16)
Involvement of the TRPML Mucolipin Channels in Viral Infections and Anti-viral Innate Immune Responses (2020) (16)
Interleukin-2 gene transfer into human transitional cell carcinoma of the urinary bladder (1999) (16)
Inhibition of Trail Gene Expression by Cyclopentenonic Prostaglandin 15-Deoxy-Δ12,14-Prostaglandin J2 in T Lymphocytes (2007) (16)
Interleukin 1-beta-induced protein kinase C-zeta activation is mimicked by exogenous phospholipase D. (1997) (15)
The global response to the COVID-19 pandemic: how have immunology societies contributed? (2020) (15)
Synthesis and use of an amphiphilic dendrimer for siRNA delivery into primary immune cells (2020) (15)
Memory NK Cell Features Exploitable in Anticancer Immunotherapy (2019) (15)
Secondary cytotoxic response in vitro against Moloney lymphoma cells antigenically altered by drug treatment in vivo. (1978) (15)
Peripheral and Intestinal CD4+ T Cells With a Regulatory Phenotype in Pediatric Patients With Inflammatory Bowel Disease (2010) (14)
Surface molecules involved in CD3‐negative NK cell function. A novel molecule which regulates the activation of a subset of human NK cells (1989) (14)
NATURAL SUPPRESSOR CELLS FOR MURINE NK ACTIVITY (1982) (14)
Post-translational Mechanisms Regulating NK Cell Activating Receptors and Their Ligands in Cancer: Potential Targets for Therapeutic Intervention (2019) (14)
An optimized retinoic acid-inducible gene I agonist M8 induces immunogenic cell death markers in human cancer cells and dendritic cell activation (2019) (14)
Granzyme A expression by normal rat natural killer (NK) cells in vivo and by interleukin 2‐activated NK cells in vitro (1989) (13)
Mu3 opiate receptor expression in lung and lung carcinoma: ligand binding and coupling to nitric oxide release. (1999) (13)
Impact of bone marrow-derived signals on NK cell development and functional maturation. (2018) (13)
Role of Aiolos and Ikaros in the Antitumor and Immunomodulatory Activity of IMiDs in Multiple Myeloma: Better to Lose Than to Find Them (2021) (13)
Induction of human NK cell-mediated cytotoxicity by CD40 triggering on antigen presenting cells. (2003) (13)
FcεRI Signaling in the Modulation of Allergic Response: Role of Mast Cell-Derived Exosomes (2020) (13)
Proliferative effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) and calcium ionophores on human large granular lymphocytes (LGL). (1988) (13)
Ca2+-activated K+ channels modulate microglia affecting motor neuron survival in hSOD1G93A mice (2018) (13)
Melanoma and immunotherapy bridge 2015 (2016) (13)
hMENA isoforms impact NSCLC patient outcome through fibronectin/β1 integrin axis (2018) (13)
Impact on NK cell functions of acute versus chronic exposure to extracellular vesicle‐associated MICA: Dual role in cancer immunosurveillance (2022) (12)
Role of the alpha 5 beta 1 integrin receptor in the proliferative response of quiescent human melanoma cells to fibronectin. (1992) (12)
The Multifunctional Role of the Chemokine System in Arthritogenic Processes (2017) (12)
C. PARVUM-INDUCED SUPPRESSOR CELLS FOR MOUSE NK ACTIVITY (1982) (12)
Ligand Interactions T Cells via OX40-OX40 + Cells and CD4 Cross-Talk between Activated Human NK (2004) (12)
NKG2A inhibits NKG2C effector functions of {gamma}{delta} T cells: implications in health and disease. (2011) (12)
Immune complexes exposed on mast cell‐derived nanovesicles amplify allergic inflammation (2019) (12)
Augmentation of Natural Killer Activity (2019) (12)
Interferon-α,β and tumor necrosis factor-α enhance the freguency of miniature end-plate potentials at rat neuromuscular junction (1994) (12)
Migration of NK cells (2006) (11)
The DNA damage response : a common pathway in the regulation of NKG 2 D and DNAM-1 ligand expression in normal , infected , and cancer cells (2018) (11)
Macrophages and interdigitating reticulum cells in normal human thymus and thymomas: immunoreactivity for interleukin‐1 alpha, interleukin‐1 beta and tumour necrosis factor alpha (1990) (11)
SAMHD1 phosphorylation and cytoplasmic relocalization after human cytomegalovirus infection limits its antiviral activity (2020) (11)
Insulin potentiates FcepsilonRI-mediated signaling in mouse bone marrow-derived mast cells. (2010) (11)
ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments (2021) (11)
GTP-binding proteins transduce signals generated via human FC gamma receptor IIIA (CD16). (1991) (10)
Differential microRNA expression between decidual and peripheral blood natural killer cells in early pregnancy (2018) (10)
Interaction of natural killer cells with extracellular matrix induces early intracellular signalling events and enhances cytotoxic functions. (1997) (10)
Activation of liver X receptor up‐regulates the expression of the NKG2D ligands MICA and MICB in multiple myeloma through different molecular mechanisms (2019) (10)
Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG 2 D and inhibits natural killer cell-mediated cytotoxicity (2006) (10)
Transcriptional modulation of a human monocytic cell line exposed to PM(10) from an urban area. (2011) (10)
Defective Th1 and Th2 cytokine synthesis in the T‐T cell presentation model for lack of CD40/CD40 ligand interaction (1998) (10)
The homeobox transcription factor MEIS2 is a regulator of cancer cell survival and IMiDs activity in Multiple Myeloma: modulation by Bromodomain and Extra-Terminal (BET) protein inhibitors (2019) (10)
Peripheral blood T cell alterations in newly diagnosed diffuse large B cell lymphoma patients and their long-term dynamics upon rituximab-based chemoimmunotherapy (2017) (10)
Overnight incubation of mouse spleen cells in recombinant IL-2 generates cytotoxic cells with NK characteristics from precursors enriched with or devoid of LGL. (1989) (10)
β1-integrin expression and function in human bladder cancer cells: Modulation by TNFα (1996) (10)
Negative regulation of innate lymphoid cell responses in inflammation and cancer. (2019) (10)
Laminin synthesis by NK cells and modulation of its expression by TPA (12-O-tetradecanoylphorbol-13-acetate). (1989) (10)
Mechanosensation and Mechanotransduction in Natural Killer Cells (2021) (9)
In vivo phenotypic characteristics of AKR T‐cell lymphomas with different leukemic potential: Possible role of α4β7 integrin in the progression towards the leukemic phenotype (1994) (9)
The Human Antibody Fragment DIATHIS1 Specific for CEACAM1 Enhances Natural Killer Cell Cytotoxicity Against Melanoma Cell Lines In Vitro (2015) (9)
Interferon-alpha, beta and tumor necrosis factor-alpha enhance the frequency of miniature end-plate potentials at rat neuromuscular junction. (1994) (9)
Perilymphatic injections of cytokines: a new tool in active cancer immunotherapy. Experimental rationale and clinical findings. (1990) (9)
Tumor inhibition or tumor promotion? The duplicity of CXCR3 in cancer (2020) (9)
The pathophysiological role of chemokines in the regulation of NK cell tissue homing. (2014) (9)
Immunogenicity of "nonimmunogenic" tumors. (1984) (8)
TNF Impairs In Vivo and In Vitro Natural Killer (NK) Susceptibility of B16 Melanoma Cells (1992) (8)
Cancer extracellular vesicles as novel regulators of NK cell response. (2019) (8)
Sequential metabolic events and morphological changes during in vivo large granular lymphocyte activation and proliferation. (1986) (8)
Expression of transduced carcinoembryonic antigen gene in human rhabdomyosarcoma inhibits metastasis. (1996) (8)
Mandatory vaccination in Italy: Time for engagement of immunologists (2018) (8)
Modulation of natural killer activity in mice by prolonged administration of various doses of dietary retinoids. (1986) (8)
Response to comment on Multifunctional human CD56lowCD16low NK cells are the prominent subset in bone marrow of both pediatric healthy donors and leukemic patients (2015) (8)
Physiological and pathological influences of central nervous system on the immune system: a critical appraisal. (1984) (8)
Cbl Family Proteins: Balancing FcεRI-Mediated Mast Cell and Basophil Activation (2011) (8)
Chronic cancer and non cancer pain and opioid-induced hyperalgesia share common mechanisms: neuroinflammation and central sensitization. (2020) (8)
Preliminary in vivo experimental evidence on intratumoral morphine uptake. Possible clinical implications in cancer pain and opioid responsiveness. (2002) (8)
Human T-lymphotropic retroviruses: a new member of the family. (1987) (8)
Role of CD69 in NO production by human monocytes. (1995) (7)
Negative signals from FcepsilonRI engagement attenuate mast cell functions. (2007) (7)
NK Cells and Other Cytotoxic Innate Lymphocytes in Colorectal Cancer Progression and Metastasis (2022) (7)
CD16 pre-ligation by defucosylated tumor-targeting mAb sensitizes human NK cells to γc cytokine stimulation via PI3K/mTOR axis (2020) (7)
Local administration of interleukin-2 activates lymphocytes from tumor bearing mice to recruit host immunoreactivity and inhibit tumor growth. (1987) (7)
Integrin-mediated regulation of cytokine and chemokine production by human natural killer cells. (2000) (7)
Dendritic cells modulate c‐kit expression on the edge between activation and death (2019) (7)
SH 2-containing inositol phosphatase ( SHIP-1 ) transiently translocates to raft domains and modulates CD 16-mediated cytotoxicity in human NK cells (2002) (6)
The POU-Domain Transcription Factor Oct-6/POU3F1 as a Regulator of Cellular Response to Genotoxic Stress (2019) (6)
In vitro and in vivo models to study chemokine regulation of angiogenesis. (2004) (6)
Structure and function of the CC chemokine receptor (CCR) 8. (1999) (6)
Histone‐deacetylase 8 drives the immune response and the growth of glioma (2021) (6)
NKG 2 D and DNAM-1 activating receptors and their ligands in NKT cell interactions : role in the NK cell-mediated negative regulation of T cell responses (2019) (6)
The ambiguity of opioids revealed by Immunology is changing the knowledge and the therapeutic approach in cancer and non-cancer pain: A narrative review. (2020) (6)
NK Cell Anti-Tumor Surveillance in a Myeloid Cell-Shaped Environment (2021) (6)
GM-CSF Inhibits c-Kit and SCF Expression by Bone Marrow-Derived Dendritic Cells (2017) (6)
Interleukin-2 lengthens extrajunctional acetylcholine receptor channel open time in mammalian muscle cells (1991) (6)
A DNA/Ki67-Based Flow Cytometry Assay for Cell Cycle Analysis of Antigen-Specific CD8 T Cells in Vaccinated Mice. (2021) (6)
In vitro migration of rat large granular lymphocytes. (1989) (5)
NK cell effector functions in a Chédiak-Higashi patient undergoing cord blood transplantation: Effects of in vitro treatment with IL-2. (2016) (5)
Phospholipase A2 activity and calpactin I levels in rat lymphokine-activated killer cells: correlation with the cytotoxic activity. (1996) (5)
REGULATION OF IN VIVO REACTIVITY OF NATURAL KILLER (NK) CELLS (1982) (5)
Genetic Variability of Human Cytomegalovirus Clinical Isolates Correlates With Altered Expression of Natural Killer Cell-Activating Ligands and IFN-γ (2021) (5)
T-cell restricted and unrestricted expression of transfected human interleukin-2 gene: phorbol ester- and calcium-inducible versus constitutive expression. (1990) (5)
High expression levels of IP10/CXCL10 are associated with modulation of the natural killer cell compartment in multiple myeloma (2017) (5)
Chronic Cancer Pain: Opioids within Tumor Microenvironment Affect Neuroinflammation, Tumor and Pain Evolution (2022) (5)
Functional analysis of alpha 1 beta 1 integrin in human natural killer cells. (1996) (5)
Preferentially Expressed in Th 2 But Not Th 1 Cutting Edge : The Chemokine Receptor CCR 8 Is (1998) (5)
A phase II study of advanced colorectal cancer patients treated with combination 5-fluorouracil plus leucovorin and subcutaneous interleukin-2 plus alpha interferon. (1994) (5)
Transient Receptor Potential Vanilloid 1 ( TRPV 1 ) activation induces autophagy in thymocytes through ROS-regulated AMPK and Atg 4 C pathways ” (2012) (5)
Transcriptional, Epigenetic and Pharmacological Control of JAK/STAT Pathway in NK Cells (2019) (5)
Retinoic Acid-induced Transcriptional Modulation of the Human Interferon-g Promoter* (1996) (5)
Multicolor flow cytometric analysis of TLR2 and TLR9 expression and function in NK cells from patients with ANCA‐associated vasculitis (2018) (4)
Cereblon regulates NK cell cytotoxicity and migration via Rac1 activation (2021) (4)
NK cell and ILC heterogeneity in colorectal cancer. New perspectives from high dimensional data. (2021) (4)
The Regulatory Activity of Noncoding RNAs in ILCs (2021) (4)
Blocking immune cell infiltration of the central nervous system to tame Neuroinflammation in Amyotrophic lateral sclerosis (2022) (4)
Lymphokine-Activated Tumor Inhibition (LATI) in Vivo (1987) (4)
Fine tuning of the DNAM-1/TIGIT/ligand axis in mucosal T cells and its dysregulation in pediatric inflammatory bowel diseases (IBD) (2019) (4)
Transplantation resistance of syngeneic mice against a drug-treated lymphoma derived from non-immunogenic tumor line. Abstr. (1977) (4)
NK Cell Reconstitution in Paediatric Leukemic Patients after T-Cell-Depleted HLA-Haploidentical Haematopoietic Stem Cell Transplantation Followed by the Reinfusion of iCasp9-Modified Donor T Cells (2019) (4)
Modulation of T Cell-Mediated Immune Responses by Natural Killer Cells (2010) (4)
Effects of cadmium on cytotoxic functions of human natural killer cells. (1991) (4)
Immunomodulatory effect of NEDD8-activating enzyme inhibition in Multiple Myeloma: upregulation of NKG2D ligands and sensitization to Natural Killer cell recognition (2021) (4)
Identification of a Genetic Variation in ERAP 1 Aminopeptidase that Prevents Human Cytomegalovirus miR-UL 1125 p-Mediated Immunoevasion Graphical (2017) (3)
Soluble factors produced by normal or tumor cells, inhibiting the uptake of 5-iodo-2'-deoxy-uridine by cancer cells in vitro. (1978) (3)
Human NK Cells Express on Cell Surface an Integrin Structure Which Mediate Their Adhesion to Fibronectin1 (1990) (3)
Enriched Environment Cues Suggest a New Strategy to Counteract Glioma: Engineered rAAV2-IL-15 Microglia Modulate the Tumor Microenvironment (2021) (3)
beta 1-Integrin expression and function in human bladder cancer cells: modulation by TNF alpha. (1996) (3)
Adhesion and activation molecules expressed by human natural killer cells (1991) (3)
Mechanisms involved in the activation and function of natural killer cells (1988) (3)
Erratum: Interferon-α,β and tumor necrosis factor-α enhance the frequency of miniature end-plate potentials at rat neuromuscular junction (Neuroscience Letters 166 (1994) 97-100) (1994) (3)
Effect of a new de-N-acetyl-lysoglycosphingolipid on some tumour models. (1995) (3)
OMIP‐079: Cell cycle of CD4 + and CD8 + naïve/memory T cell subsets, and of Treg cells from mouse spleen (2021) (3)
Phenotypically and Functionally Altered T Cell Compartment in DLBCL Patients at Diagnosis and Its Long-Term Modification upon Chemoimmunotherapy Regimen (2015) (2)
Anti-CD 20 Therapy Acts via Fc g RIIIA to Diminish Responsiveness of Human Natural Killer Cells (2015) (2)
Receptor Signal Transduction and Cytokine Gene Expression in T Lymphocytes (1994) (2)
Secondary cytotoxic tumor immune response induced in vitro against a drug altered tumor (1976) (2)
HLA-A 2-Restricted Peptides and to Induce Deliver MAGE-A 10 or MAGE-A 3 to fd The Use of Filamentous Bacteriophage (2008) (2)
LAMININ PRODUCTION BY NATURAL KILLER CELLS (1987) (2)
In vivo imaging of NK cell trafficking in tumors (2015) (2)
NK cells and chemokines (2010) (2)
NK receptors and signalling. (1997) (2)
Expression and Synthesis of Fibronectin by Natural Killer Cells: Possible Involvement in the NK-Target Cell Interaction1 (1989) (2)
Monitoring of macrophage activation by immunoadjuvants in mice as judged by functional criteria. (1978) (1)
Immunity and pain: is it time for the birth of immunoalgology? (2021) (1)
Improved memory CD8 T cell response to delayed vaccine boost is associated with a distinct molecular signature (2022) (1)
UniVax Day 2018 ‐ Outreach to high school students to improve vaccination rates (2018) (1)
Regulation of muscle acetylcholine receptor-channel function by interferon (1989) (1)
In vitro andin vivo impact of a new glycosphingolipid on neutrophils (1994) (1)
Immunology and Algology speak a common language - Editorial. (2020) (1)
Immunometabolism pathways as the basis for innovative anti-viral strategies (INITIATE): A Marie Sklodowska-Curie innovative training network (2020) (1)
Abstract 4935: Ex vivo Acidic Preconditioning Modulates Bone Marrow-derived ckit+ Cell Function in vitro and Enhances Their Therapeutic Potential in a Mouse Model of Hindlimb Ischemia (2009) (1)
Imbalance of immune functions in progressive systemic sclerosis patients (1988) (1)
The Cbl family of ubiquitin ligases regulates FcεRI expression and mast cell activation (2013) (1)
Induction of Ca2+ flux by adhesion molecules in lymphocytes. (1999) (1)
Estrogen and antiestrogen modulation of mouse natural killer (NK) activity and large granular lymphocytes (LGL) (1985) (1)
Cytotoxic Function of Human NK Cells Regulated Kinase Activation , Leading to CD 16-Triggered Syk and Extracellular CD 94 / NKG 2-A Inhibitory Complex Blocks Santoni (1999) (1)
Augmentation of mouse natural killer (NK) activity by GM-1/P, a processed form of monosialoganglioside GM-1. (1990) (1)
T-Cell Derived Suppressor Factors in the Regulation of Humoral Immunity (1988) (1)
ALTERATIONS IN NUMBERS OF LGLs AS IMPORTANT COMPONENT OF IN VIVO REGULATION OF NK ACTIVITY (1985) (1)
Role of Natural Killer Cells in Sonic Hedgehog driven Medulloblastoma (2017) (1)
Immunomodulation of natural reactivities against tumors (1979) (1)
Preferentially Expressed in Th2 But Not Th1 Cutting Edge: The Chemokine Receptor CCR8 Is (2012) (1)
Characterization of Corynebacterium parvum-induced suppressor cells of mouse NK and ADCC activity. (1990) (1)
GAS6/TAM signaling pathway controls MICA expression in multiple myeloma cells (2022) (1)
Editorial: TGF-β as a Key Regulator of NK and ILCs Development and Functions (2021) (1)
Tools and Technologies Cancer-Associated CD 43 Glycoforms as Target of Immunotherapy (2014) (1)
Age-dependent NK cell dysfunctions in severe COVID-19 patients (2022) (1)
NK cells acquire PD-1 from the membrane of tumor cells. (2020) (1)
NK cell and endothelial cell interactions (2010) (1)
Inhibition of NK cell generation by Corynebacterium parvum. (1991) (1)
CD16 aggregation induced by therapeutic antibody-opsonised targets impairs cytotoxic responses in human NK cells (2013) (1)
Polyclonal Antibodies Against gp185HER2 Peptides: Their Putative Role in the Identification of a Particular HER2 Status in Patients With Breast Cancer (2001) (0)
Abstract A040: The low antitumor functionality of PD1-positive gp100-specific CD8+ T cell clones isolated from melanoma patients correlates with the presence of CD28 co-stimulatory molecule (2016) (0)
Locoregional IL-2 immunotherapy of bladder cancer. (1997) (0)
pregnancy mechanism controlling NK cell accumulation in the uterus during early Recruitment of circulating NK cells through decidual tissues: a possible (2010) (0)
The multifaceted role of PIP2 in leukocyte biology (2015) (0)
546 hMena overexpression cooperates with HER2 signalling in breast cancer (2010) (0)
Down-Regulation of the Activating Receptor NKG2D by its Ligands Expressed on T Lymphocytes: A New Mechanism to Limit CD8+ T Cell Immune Responses. (2008) (0)
STUDY OF INNATE IMMUNITY AND THE EFFECT OF IVIG INFUSIONS IN PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY AND X-LINKED AGAMMAGLOBULINEMIA PhD COURSE IN IMMUNOLOGICAL, HAEMATOLOGICAL AND RHEUMATOLOGICAL SCIENCES CLINICAL IMMUNOLOGY XXIX CYCLE (2017) (0)
Effect of immunopharmacologic treatment on anti-tumor immune response in lethally irradiated mice. (1978) (0)
Correlation of natural cytotoxicity against mouse tumors with antibody-dependent cell-mediated cytotoxicity. Abstr. (1977) (0)
Immunomodulatory Effects Of Bovine Lactoferrin On Antigen Presenting Cells (2012) (0)
Manipulation of the immune response against tumors (1984) (0)
Stimulatory and inhibitory effects on mouse natural killer (NK) activity by in vivo treatment with pyran copolymer (1979) (0)
Transcriptional Factor E 2 F 1 Transcriptional Levels and Requires the Ligand Upregulation Occurs at Dependent NK Cell Activating − Response and DNA Damage − Reactive Oxygen Species (2014) (0)
Cell Functional Interactions Dendritic - Activin A as a Mediator of NK (2013) (0)
Thymus and in Thymoma (2007) (0)
Abstract A003: Polyfunctional antitumor CD8 T cells obtained from a broad repertoire elicited by chemo-immunotherapy and preventing melanoma relapse depends on the activation of an AKT pathway sustained by ICOS (2016) (0)
Modulation of CD16 Antigen on NK Cells and Granulocytes by Protein Kinase C Activators and Inhibitors1 (1990) (0)
Integrin-mediated stimulation of tyrosine phosphorylation in lymphoid cells. (1999) (0)
The direct Interaction with dsRNA triggers signalling and functional events in Human NK Cells (2004) (0)
Coupling of β1 integrin to RAS-MAP kinase pathways controls IFNγ mRNA expression in human NK cells (1998) (0)
Modulation of natural killer cell (NK) activity and large granular lymphocytes (LGL) number by 17-β-estradiol (E2) (1985) (0)
beta 1 integrin ligation induce cytokine and chemokine expression in human NK cells. (1999) (0)
Mechanisms for in vivo Expansion of Natural Killer Cells1 (1986) (0)
MigrationReceptors Controls NK Cell Transendothelial Activation by Chemokine and Integrin Proline-Rich Tyrosine Kinase 2 and Rac (2003) (0)
KLRG1+ NK Cells Include Two Distinct Populations Lined by CX3CR1 Expression (2010) (0)
Altered distribution of neutrophils and Nk cells in collagenase-induced osteoarthritis (2012) (0)
Evaluation of Rho family small G-protein activity induced by integrin ligation on human leukocytes. (2004) (0)
PhD in IMMUNOLOGICAL SCIENCE CICLE XXV “Immunophenotipic and molecular characterization of EBV-driven age-related lymphoproliferative disorders” (2013) (0)
Transcriptional Levels and Requires the Ligand Upregulation Occurs at Dependent NK Cell Activating - Response and DNA Damage - Reactive Oxygen Species (2014) (0)
Cytotoxic effectors expanded from acute myeloid leukemia (AML) patients in complete hematologic remission show lytic activity against autologous blasts (2000) (0)
When damage prevents cancer: the activation of the DNA damage response regulate the expression of DNAM-1 and NKG2D activating receptor ligands on human multiple myeloma cells (2008) (0)
DegranulationTheir Ability to Trigger NK Cell Expression on Multiple Myeloma Cells and MHC Class I-Related Chain A and B Ligand Heat Shock Protein-90 Inhibitors Increase (2009) (0)
Arf6: a new player in Fc (cid:1) RIIIA lymphocyte-mediated cytotoxicity (2005) (0)
Early molecular events in cd69-mediated platelet activation (1993) (0)
Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation (2015) (0)
Estradiol (E2) increases the sensitivity of MCF-7 human breast cancer cells to natural killer (NK) cell activity (1987) (0)
A previously missed population of antigen-specific CD8 T cells divides in the blood after vaccination (2018) (0)
Role of NF-κB Signaling in the Interplay between Multiple Myeloma and Mesenchymal Stromal Cells (2023) (0)
Effects ofsodiumfusidate inanimal modelsofinsulin-dependent diabetes mellitus andseptic shock (1995) (0)
Hyporesponsiveness of Natural Killer Activity Induced in Vivo By Multiple Treatment with Maleic Acid Anhydride Divinyl Ether (MVE-2) (1984) (0)
Natural killer cells as regulators of T cell-mediated immune responses. (2006) (0)
Corrigendum: Improved memory CD8 T cell response to delayed vaccine boost is associated with a distinct molecular signature (2023) (0)
Phenotypic And Functional Long-Term Dynamics Of Peripheral Blood Natural Killer Cell Compartment In Diffuse-Large-B-Cell Lymphoma Patients Before And After R-Chop-Based Immunochemotherapy (2014) (0)
Fibronectin Expression by Endogenous and Activated NK Cells (1988) (0)
receptor NKG2D: role of NKG2D ligands released by activated T cells T lymphocytes by down-regulation of the activating + Detuning CD8 (2012) (0)
Innate immune activating ligand SUMOylation affects tumor cell recognition by NK cells (2017) (0)
Signalling and functional events triggered in human Natural Killer (NK) cells by recognition of dsRNA (2004) (0)
Interplay between the c-kit/Stem Cell Factor axis and the TLR ligands CpG and Polyl:C in mouse Dendritic Cells (2015) (0)
Phenotypical and functional characterization of peripheral blood natural killer cells in spondyloarthropathy patients (2007) (0)
Down-regulation of the NKG2D receptor is differentiallycontrolled by MICA and ULBP2 ligands (2013) (0)
Polyclonal antibodies against gp185HER2 peptides: their putative role in the identification of a particular HER2 status in patients with breast cancer. (2001) (0)
Negative regulation of FCεRI-mediated basophil activation by the CBL family of adaptor proteins (2011) (0)
Doxorubicin–Mediated miR–433 Expression on Exosomes Promotes Bystander Senescence in Multiple Myeloma Cells in a DDR–Independent Manner (2023) (0)
Symposium: Current knowledge on natural killer cells, pregnancy and pre-eclampsia Uterine NK cell development, migration and (2008) (0)
Negative signals from FcepsilonRI engagement attenuate receptor-mediated mast cell functions (2005) (0)
Cytotoxicity in Multiple Myeloma Cells: Mediated − and Sensitivity to NK Cell Increases NKG2D Ligand MICA Expression Inhibition of Glycogen Synthase Kinase-3 (2013) (0)
Degranulation Phospholipase D in CD16-Triggered Exocytosis in Human NK cells: Role of Phospholipase A2 Activity and Granule Secretory CD16-Induced Phospholipase D and 1 Integrin Cross-Linking Inhibits β (2013) (0)
[Selective inhibition of the response to the allograft of a virus in mice]. (1975) (0)
Status of Constitutive Activation and Transient Hyporeactivity of T-lymphocytes of Human Intestinal Mucosa (1993) (0)
Editorial-innate lymphoid cells, a new key component of the immune system. (2021) (0)
[Antigenic characteristics of hamster cells transformed by polyoma virus]. (1975) (0)
Alterations of NKG2D/ligands pathway in pediatric IBD (2008) (0)
Activation-Dependent Regulation of β1 Integrin Expression and Function in Human Natural Killer Cells (1993) (0)
The homeobox transcription factor MEIS2 is a regulator of cancer cell survival and IMiDs activity in Multiple Myeloma: modulation by Bromodomain and Extra-Terminal (BET) protein inhibitors (2019) (0)
Interleukin-2 Patients Treated with Intraarterial Infusion of Recombinant Local Activation of Immune Response in Bladder Cancer (2006) (0)
ARF6: A NEW PLAYER IN THE FcγRIIIA LYMPHOCYTE-MEDIATED CYTOTOXICITY Running title: A role for Arf6 in lymphocyte-mediated cytotoxicity (2005) (0)
Cadmium-induced inhibition of human lymphocyte proliferation (1988) (0)
Soluble and cell-associated IL-2 receptor (IL-2R) after local immunotherapy with recombinant interleukin-2 (rIL-2). (1992) (0)
cytotoxicity and cytokine production in human NK cells p38 MAPK activation controls the TLR3-mediated up-regulation of (2013) (0)
Natural killer cells modulate motor neuron-immune cell cross talk in models of Amyotrophic Lateral Sclerosis (2020) (0)
Enhancement of IL-2 production and responsiveness by GM-1/P (1988) (0)
Cloning of human and murine TER1, an orphan chemokine receptor expressed by lymphoid tissues, and CHR3 a seven transmembrane spanning receptor (1997) (0)
Human NK Cells CD 69-Mediated Signaling and Function on Src-Dependent Syk Activation Controls Santoni (2002) (0)
Melanoma and immunotherapy bridge 2015 (2016) (0)
Author response for "Dendritic Cells modulate c-kit expression on the edge between activation and death" (2018) (0)
Detuning CD8 (cid:1) T lymphocytes by down-regulation of the activating receptor NKG2D: role of NKG2D ligands released by activated T cells (2009) (0)
Short Title: chemokines regulate BM NK cell mobilization (2013) (0)
The activation of the DNA damage response regulate the expression of DNAM-1 and NKG2D activating receptor ligands on human multiple myeloma (MM) cells. (2008) (0)
Ubiquitin and ubiquitin-like modifiers modulate NK cell-mediated recognition and killing of damaged cells (2017) (0)
-Prostaglandin J2 Inhibits CD95 Ligand Gene Expression in T Lymphocytes: Interference with Promoter Activation Via Peroxisome Proliferator-Activated Receptor- -Independent Mechanisms (2003) (0)
Spontaneous in vivo cytolytic activity of mice against tumor cells. Abstr. (1979) (0)
INTERNATIONAL RETREAT OF PhD STUDENTS IN IMMUNOLOGY (2015) (0)
TNFα Negatively Affects Natural Killer Susceptibility of B 16 Melanoma1 (1990) (0)
Marrow Memory Occurs Predominantly in the Bone CD 8 Cell Division Maintaining Cytotoxic (2005) (0)
IL-2 and Lymphocytes from Tumor Bearing Mice: A Combinatory Immunotherapy of Tumors (1984) (0)
Age influence on radioresistant inhibition of tumors (rit) in mice. Abstr. (1978) (0)
Role of redox-activated DNA damage response in the regulation of drug-induced NKG 2 D and DNAM-1 ligand expression on human senescent multiple myeloma cells (2012) (0)
Distinct Phenotypic and Functional Immunological Alterations Characterize the Peripheral Blood Compartment of Patients with Diffuse Large B Cell Lymphoma (DLBCL). (2012) (0)
Natural killer cells in scleroderma (1992) (0)
NKG2D engagement on human NK cells leads to DNAM‐1 hypo‐responsiveness through different converging mechanisms (2022) (0)
Regulation of NKG2D and DNAM-1 ligand expression in HCMV infected fibroblasts: role of the DNA damage response pathway and of viral replication (2013) (0)
Tyrosine Phosphory la t i on and Their B ind ing wi th Grb 2 in H u m a n Natural Killer Cells (2003) (0)
Synthesis of 99mTc-anti-CD56 Monoclonal Antibody for Molecular Imaging of NK Cells (2013) (0)
Lipid raft-dependent FcepsilonRI ubiquitination controls endocytosis of engaged receptors in mast cells (2008) (0)
Laminin expression by rat lymphoid cells (1988) (0)
Epitelial-to-mesenchimal transition and invasion are upmodulated by tumor-expressed granzyme B and inhibited by docosahexaenoic acid in human colorectal cancer cells (2016) (0)
Regulation of mouse natural killer (NK) activity by interferon-γ (IFN-γ) (1985) (0)
Ubiquitin-Proteasome Degradation Pathway Tyrosine Kinase Level by Activating the The Adaptor Molecule CIN85 Regulates Syk (2013) (0)
CytotoxicitySignaling Pathways Leading to NK Cell Role for the Rac1 Exchange Factor Vav in the (1999) (0)
Syk regulates ligand-induced FcepsilonRI down-modulation and degradation in mast cells (2008) (0)
Signal Transduction during NK Cell Activation via CD 16: G Proteins Regulate Inositol Phosphate Generation and ADCC Activity1 (1990) (0)
Correction: Kinetics of In Vivo Proliferation and Death of Memory and Naive CD8 Cells: Parameter Estimation Based on 5-Bromo-2′-Deoxyuridine Incorporation in Spleen, Lymph Nodes, and Bone Marrow (2016) (0)
in T Lymphocytes 3 Expression by Vitamin D Negative Regulation of CD95 Ligand Gene (2002) (0)
WAS and XLT: ability of IL-2 to correct NK cell functional defect Impaired natural and CD16-mediated NK cell cytotoxicity in patients with (2013) (0)
Syk kinase activity controls the coupling of engaged FcepsilonRI to the endocytic pathway (2009) (0)
Synthesis and use of an amphiphilic dendrimer for siRNA delivery into primary immune cells (2020) (0)
RIIIA lymphocyte-mediated cytotoxicity γ ARF6: A new player in the Fc (2013) (0)
Reduction of LGLs number by multiple treatment with MVE-2 (1984) (0)
This information is current as of Experimental Osteoarthritis NK Cell Cross-Talk Determining the Severity − CXCR 3 / CXCL 10 Axis Regulates Neutrophil (2017) (0)
Regulation and function of fibronectin receptors expressed by natural killer cells. (1994) (0)
PHENOTYPIC AND FUNCTIONAL CHARACTERIZATION OF THE CD56DIMCD16LOW NK CELL SUBSET IN BONE MARROW AND PERIPHERAL BLOOD OF HEALTHY DONORS. (2013) (0)
In vivo phenotypic characteristics of AKR T-cell lymphomas with different leukemic potential: possible role of alpha 4 beta 7 integrin in the progression towards the leukemic phenotype. (1994) (0)
[Study of the expression of neoplasm transplantation antigens and S antigens in hamster cells, transformed by para-adenovirus 7]. (1974) (0)
PhD school in: Immunological, Hematological and Rheumatological Sciences (SIER) XXVIII cycle Curriculum: Immunology and Immunopathology TITLE “Molecular characterization and immunomodulatory properties of MM cell-derived exosomes on NK cell-mediated functions: role of Toll-like receptor 2” (2016) (0)
[Effects of treatment with neuraminidase on the immunogenicity of ATPC tumor cells]. (1973) (0)
‘PD-1 related effector functions rely on the presence/absence of CD28 co-stimulatory molecule in Ag-specific CD8+ T cell clones isolated from melanoma patients’ (2016) (0)
Effect of prolonged administration of low doses of dietary retinoids on cell mediated immunity and on the growth of transplantable tumors (1985) (0)
Differential interaction of Shc-SH2 domain with FcγRIII (CD16)-associated ζ and γ chains (1996) (0)
Promoting Their Entry into Circulation NK Cells into the Bone Marrow by + KLRG1CX3CR1 Regulates the Maintenance of (2013) (0)
to autologous NK- cell lysis susceptible ligands via an ATM/ATR-dependent mechanism and become Antigen-activated human T lymphocytes express cell-surface NKG2D (2013) (0)
Molecular signals coupling the low affinity Fcgamma receptor to phosphoinositide metabolism regulates natural killer cell-mediated cytotoxic function (2005) (0)
Expression pattern and functional role of DNAM-1 family co-receptors on mucosal and peripheral blood T cell populations of pediatric subjects and Inflammatory Bowel Diseases (IBD) patients. (2014) (0)
Role of the a$ÃŸiIntegrin Receptor in the Proliferative Response of Quiescent Human Melanoma Cells to Fibronectin1 (2006) (0)
Mouse dendritic cells in the steady state: Hypoxia, autophagy, and stem cell factor (2022) (0)
AB0040 Role of Innate Immunity in the Pathogenesis of Anca-Associated Vasculitis (2014) (0)
NK CELLS IN PREGNANCY (2010) (0)
Neutrophil diversity and plasticity in tumour progression and therapy (2020) (0)
DevelopmentTrophoblast Invasion and Placental and Tissue Remodeling: Contribution to An Alternative Role of C1q in Cell Migration (2010) (0)
In vivo interleukin 2 (IL 2) converts non reactive lymphocytes from tumor bearing mice in cells able to block tumor growth (1984) (0)
Fabrizio Eusebi (1945–2009) (2010) (0)
Integrine e cellule Natural Killer (NK) (2000) (0)
Cell-Mediated Natural Cytotoxicity Proline-Rich Tyrosine Kinase 2 in NK Cutting Edge: Functional Role for (2000) (0)
“Chemerin/chemerin receptor axis plays a role in the accumulation of NK cells in the decidua during pregnancy” (2011) (0)
Interleukin-1 receptor 8 (IL-1R8) plays a crucial role in natural killer (NK) cell differentiation and function (2015) (0)
2270 – IMMUNOENHANCING EFFECT OF ADRIAMYCIN ON RESISTANCE OF LETHALLY IRRADIATED MICE AGAINST TUMOR GRAFTS (1978) (0)
Corrigendum (2017) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Angela Santoni?

Angela Santoni is affiliated with the following schools:

Angela Santoni's Academic­Influence.com Rankings